Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2009 - 2026)

Regeneron Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 49.84 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio fell 26.72% year-over-year to 49.84; the TTM figure through Mar 2026 stood at 75.61 (down 5.66% YoY), while the FY2025 annual figure was 81.69, up 12.99% from the prior year.
• Interest Coverage Ratio was 49.84 for Q1 2026 at Regeneron Pharmaceuticals, down from 72.12 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 299.86 in Q2 2025 to a low of 46.67 in Q1 2024.
• Historically, Interest Coverage Ratio has averaged 81.58 across 5 years, with a median of 68.01 in 2025.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio tumbled 64.8% in 2022, then jumped 314.92% in 2025.
• A 5-year view of Interest Coverage Ratio shows it stood at 65.91 in 2022, then slipped by 19.34% to 53.16 in 2023, then surged by 77.38% to 94.3 in 2024, then fell by 23.52% to 72.12 in 2025, then sank by 30.9% to 49.84 in 2026.
• The last three Interest Coverage Ratio figures came in at 49.84 (Q1 2026), 72.12 (Q4 2025), and 53.2 (Q3 2025), per Business Quant data.